Janusz Milanowski

Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer.

G. Scagliotti, J. Milanowski, F. Shepherd, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia

A. Abernethy, J. Milanowski, J. Temel, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection

P. Krawczyk, E. Kalinka, A. Grenda, 2024, International journal of molecular sciences.

Pembrolizumab-combination therapy for NSCLC- effectiveness and predictive factors in real-world practice

P. Krawczyk, D. Kowalski, E. Kalinka, 2024, Frontiers in oncology.

Prevalence of rare EGFR gene mutations in nonsmall-cell lung cancer: a multicenter study on 3856 Polish Caucasian patients.

P. Krawczyk, R. Ramlau, A. Szczesna, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunological insights: assessing immune parameters in medical professionals exposed to SARS-CoV-2

P. Krawczyk, A. Grenda, K. Wojas-Krawczyk, 2024, BMC infectious diseases.